Publications

  1. Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE. Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging. 2014 Dec 02.
    View PubMed
  2. Winston DJ, Vikram HR, Rabe IB, Dhillon G, Mulligan D, Hong JC, Busuttil RW, Nowicki MJ, Mone T, Civen R, Tecle SA, Trivedi KK, Hocevar SN, West Nile Virus Transplant-Associated Transmission Investigation Team. Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features. Transplantation. 2014 May 15; 97(9):881-9.
    View PubMed
  3. Carpenter SG, Grimsby G, DeMasters T, Katariya N, Hewitt WR, Moss AA, Reddy KS, Castle EP, Mulligan DC. Robotic resection of choledochocele in an adult with intracorporeal hepaticojejunostomy and Roux-en-Y anastomosis: Encouraging progress for robotic surgical treatment of biliary disease. Journal of Robotic Surgery. 2014; 8(1):77-80.
  4. Ashman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M. Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer. J Gastrointest Oncol. 2013 Dec; 4(4):352-60.
    View PubMed
  5. *Hsieh TH, Mekeel KL, Crowell MD, Nguyen CC, Das A, Aqel BA, Carey EJ, Byrne TJ, Vargas HE, Douglas DD, Mulligan DC, Harrison ME. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc. 2013 Jan; 77(1):47-54 Epub 2012 Oct 11.
    View PubMed
  6. Chakkera HA, Chang YH, Bodner JK, Behmen S, Heilman RL, Reddy KS, Mulligan DC, Moss AA, Khamash H, Katariya N, Hewitt WR, Pitta TL, Frassetto LA. Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. Transplant Proc. 2013 Jan-Feb; 45(1):137-41.
    View PubMed
  7. Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database. J Transplant. 2013; 2013:269096. Epub 2013 Sep 24.
    View PubMed
  8. Martin AD, Mekeel KL, Castle EP, Vaish SS, Martin GL, Moss AA, Mulligan DC, Heilman RL, Reddy KS, Andrews PE. Laparoscopic bilateral native nephrectomies with simultaneous kidney transplantation. BJU Int. 2012 Dec; 110(11 Pt C):E1003-7. Epub 2012 Aug 09.
    View PubMed
  9. Kusne S, Vilchez RA, Zanwar P, Quiroz J, Mazur MJ, Heilman RL, Mulligan D, Butel JS. Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. J Infect Dis. 2012 Sep 15; 206(6):875-80. Epub 2012 Jul 16.
    View PubMed
  10. Pruett TL, Blumberg EA, Cohen DJ, Crippin JS, Freeman RB, Hanto DW, Mulligan DC, Green MD. A consolidated biovigilance system for blood, tissue and organs: one size does not fit all. Am J Transplant. 2012 May; 12(5):1099-101. Epub 2012 Apr 09.
    View PubMed
  11. Tyson MD, Castle EP, Andrews PE, Heilman RL, Moss AA, Mulligan DC, Reddy KS. Ureteral stricture formation in laparoscopically procured living donor kidney transplantation. Can J Urol. 2012 Apr; 19(2):6188-92.
    View PubMed
  12. Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA. Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transplant. 2012; 2012:614781. Epub 2012 Jan 29.
    View PubMed
  13. Rosenfeld DM, Trentman TL, Simula DV, Ivancic MG, Poterack KA, Weinmeister KP, Seamans DP, Mulligan DC, Noble BN. Adult live donor hepatectomy: a retrospective pilot study comparing four strategies of perioperative pain control. J Transplant Technol Res. 2012; S1-007.
  14. Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec; 17(12):1394-403.
    View PubMed
  15. Mazur MJ, Lowney AC, Prigoff J, Heilman RL, Chakkera H, Moss A, Mulligan D, Reddy K, Hamawi K. Resolution of long-standing necrobiosis lipoidica diabeticorum (NLD) lesion after restoration of euglycemia following successful pancreas after kidney (PAK) transplantation: a case report. Transplant Proc. 2011 Nov; 43(9):3296-8.
    View PubMed
  16. Mekeel KL, Moss AA, Reddy KS, Mulligan DC, Harold KL. Laparoscopic distal pancreatectomy: does splenic preservation affect outcomes? Surg Laparosc Endosc Percutan Tech. 2011 Oct; 21(5):362-5.
    View PubMed
  17. Chakkera HA, Weil EJ, Swanson CM, Dueck AC, Heilman RL, Reddy KS, Hamawi K, Khamash H, Moss AA, Mulligan DC, Katariya N, Knowler WC. Pretransplant risk score for new-onset diabetes after kidney transplantation. Diabetes Care. 2011 Oct; 34(10):2141-5.
    View PubMed
  18. Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK. Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants. Transplantation. 2011 Sep 15; 92(5):570-4.
    View PubMed
  19. Mekeel KL, Moss AA, Mulligan DC, Reddy KS. A technique for kidney retransplantation after simultaneous kidney pancreas transplantation. Transplant Proc. 2011 Jun; 43(5):1627-8.
    View PubMed
  20. Tyson MD, Castle EP, Ko EY, Andrews PE, Heilman RL, Mekeel KL, Moss AA, Mulligan DC, Reddy KS. Living donor kidney transplantation with multiple renal arteries in the laparoscopic era. Urology. 2011 May; 77(5):1116-21. Epub 2010 Dec 08.
    View PubMed
  21. Mekeel KL, Moss AA, Mulligan DC, Reddy KS. Open sphincteroplasty for benign ampullary stricture after pancreas transplantation. Am J Transplant. 2011 Feb; 11(2):399-402. Epub 2011 Jan 07.
    View PubMed
  22. Heilman RL, Nijim S, Chakkera HA, Devarapalli Y, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS. Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal. J Transplant. 2011; 2011:583981. Epub 2011 May 15.
    View PubMed
  23. Tyson MD, Castle EP, Ko EY, Andrews PE, Heilman RL, Mekeel KL, Moss AA, Mulligan DC, Reddy KS. Living donor kidney transplantation with multiple renal arteries in the laparoscopic era. International Braz J Urol. 2011; 37(3):401.
  24. Grotz TE, Nagorney D, Donohue J, Que F, Kendrick M, Farnell M, Harmsen S, Mulligan D, Nguyen J, Rosen C, Reid-Lombardo KM. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford). 2010 Oct; 12(8):546-53. Epub 2010 Sep 02.
    View PubMed
  25. Grotz TE, Nagorney D, Donohue J, Que F, Kendrick M, Farnell M, Harmsen S, Mulligan D, Nguyen J, Rosen C, Reid-Lombardo KM. Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford). 2010 Oct; 12(8):546-53. Epub 2010 Sep 02.
    View PubMed
  26. Tyson M, Castle E, Andrews P, Heilman R, Mekeel K, Moss A, Mulligan D, Reddy K. Early graft function after laparoscopically procured living donor kidney transplantation. J Urol. 2010 Oct; 184(4):1434-9. Epub 2010 Aug 19.
    View PubMed
  27. Chakkera HA, Knowler WC, Devarapalli Y, Weil EJ, Heilman RL, Dueck A, Mulligan DC, Reddy KS, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Castro JC, Cook CB. Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1669-75. Epub 2010 Jun 17.
    View PubMed
  28. Chakkera HA, Bodner JK, Heilman RL, Mulligan DC, Moss AA, Mekeel KL, Mazur MJ, Hamawi K, Ray RM, Beck GL, Reddy KS. Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus. Transplant Proc. 2010 Sep; 42(7):2650-2.
    View PubMed
  29. Reddy KS, Devarapalli Y, Mazur M, Hamawi K, Chakkera H, Moss A, Mekeel K, Post D, Heilman R, Mulligan D. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: comparison to induction with antithymocyte globulin. Transplant Proc. 2010 Jul-Aug; 42(6):2006-8.
    View PubMed
  30. Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B, Schweitzer E, Ganz S, Caliendo A, Orlowski JP, Wilson B, Kotton C, Michaels M, Kleinman S, Geier S, Murphy B, Green M, Levi M, Knoll G, Segev D, Brubaker S, Hasz R, Lebovitz DJ, Mulligan Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant. 2010 Apr; 10(4):889-99. Epub 2010 Jan 29.
    View PubMed
  31. Heilman RL, Devarapalli Y, Chakkera HA, Mekeel KL, Moss AA, Mulligan DC, Mazur MJ, Hamawi K, Williams JW, Reddy KS. Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant. 2010 Mar; 10(3):563-70. Epub 2010 Feb 01.
    View PubMed
  32. Mekeel KL, Daley SM, Andrews PE, Moss AA, Heilman RL, Mazur MJ, Chakkera HA, Hamawi K, Mulligan DC, Sudhakar Reddy K. Successful transplantation of a split crossed fused ectopic kidney into a patient with end-stage renal disease. J Transplant. 2010; 2010:383972. Epub 2010 Mar 25.
    View PubMed
  33. Eleid MF, Hurst RT, Vargas HE, Rakela J, Mulligan DC, Appleton CP. Short-term cardiac and noncardiac mortality following liver transplantation. J Transplant. 2010; 2010. Epub 2010 Aug 12.
    View PubMed
  34. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, De Petris G, Williams JW, Rakela J, Vargas HE. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl. 2009 Dec; 15(12):1872-81.
    View PubMed
  35. Chakkera HA, Hanson RL, Raza SM, DiStefano JK, Millis MP, Heilman RL, Mulligan DC, Reddy KS, Mazur MJ, Hamawi K, Moss AA, Mekeel KL, Cerhan JR. Pilot study: association of traditional and genetic risk factors and new-onset diabetes mellitus following kidney transplantation. Transplant Proc. 2009 Dec; 41(10):4172-7.
    View PubMed
  36. Jaroszewski DE, Pierce CC, Staley LL, Wong R, Scott RR, Steidley EE, Gopalan RS, DeValeria P, Lanza L, Mulligan D, Arabia FA. Simultaneous heart and kidney transplantation after bridging with the CardioWest total artificial heart. Ann Thorac Surg. 2009 Oct; 88(4):1324-6.
    View PubMed
  37. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D'Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB, ASTS Standards on Organ Transplantation Committee. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant. 2009 Sep; 9(9):2004-11. Epub 2009 Jul 16.
    View PubMed
  38. Mekeel KL, Moss AA, Mulligan DC, Chakkera HA, Hamawi K, Mazur MJ, Heilman RL, Reddy KS. Deceased donor kidney transplantation from donors with acute renal failure due to rhabdomyolysis. Am J Transplant. 2009 Jul; 9(7):1666-70. Epub 2009 May 20.
    View PubMed
  39. Mekeel K, Moss A, Reddy KS, Douglas D, Mulligan D. Sclerosing peritonitis and mortality after liver transplantation. Liver Transpl. 2009 Apr; 15(4):435-9.
    View PubMed
  40. Chakkera HA, Weil EJ, Castro J, Heilman RL, Reddy KS, Mazur MJ, Hamawi K, Mulligan DC, Moss AA, Mekeel KL, Cosio FG, Cook CB. Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol. 2009 Apr; 4(4):853-9. Epub 2009 Apr 01.
    View PubMed
  41. *Li F, Mekeel KL, Eleid M, Harrison ME, Reddy KS, Moss AA, Mulligan DC. Hemobilia and pancreatitis after liver transplant biopsy. Liver Transpl. 2009 Mar; 15(3):350-1.
    View PubMed
  42. Heilman RL, Chakkera H, Mazur M, Petrides S, Moss A, Mekeel K, Mulligan D, Reddy KS. Outcomes of simultaneous kidney-pancreas transplantation with positive cross-match. Transplant Proc. 2009 Jan-Feb; 41(1):303-6.
    View PubMed
  43. Hastings D, Patel B, Torloni AS, Mookadam F, Betcher J, Moss A, Heilman R, Mazur M, Hamawi K, Mulligan D, Reddy K, Mekeel K, Chakkera H. Plasmapheresis therapy for rare but potentially fatal reaction to rituximab. J Clin Apher. 2009; 24(1):28-31.
    View PubMed
  44. Hamawi K, Heilman RL, Mazur MJ, Chakkera HA, Mulligan DC, Moss AA, Mekeel KL, Reddy KS. Use of bortezomib for treatment of antibody medicated rejection in kidney transplant recipients--case report. Clin Transpl. 2009; 407-14.
    View PubMed
  45. Ko EY, Castle EP, Desai PJ, Moss AA, Reddy KS, Mekeel KL, Mulligan DC, Andrews PE. Utility of the endovascular stapler for right-sided laparoscopic donor nephrectomy: a 7-year experience at Mayo Clinic. J Am Coll Surg. 2008 Dec; 207(6):896-903. Epub 2008 Aug 30.
    View PubMed
  46. Mekeel KL, Moss AA, Reddy KS, Mulligan DC, Harold KL. Laparoscopic fenestration of giant hepatic cysts. Surg Laparosc Endosc Percutan Tech. 2008 Oct; 18(5):511-3.
    View PubMed
  47. Mekeel KL, Moss AA, Reddy KS, Douglas DD, Vargas HE, Carey EJ, Byrne TJ, Harrison ME, Rakela J, Mulligan DC. Living donor liver transplantation in polycystic liver disease. Liver Transpl. 2008 May; 14(5):680-3.
    View PubMed
  48. Heilman RL, Chakkera HA, Reddy KS, Colby TV, Moss AA, Williams JW, Mazur MJ, Petrides S, Mulligan DC. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression. Clin Transplant. 2008 May-Jun; 22(3):309-15.
    View PubMed
  49. Mekeel K, Mulligan D, Reddy KS, Moss A, Harold K. Laparoscopic incisional hernia repair after liver transplantation. Liver Transpl. 2007 Nov; 13(11):1576-81.
    View PubMed
  50. Mekeel KL, Mazur MJ, Reddy KS, Mulligan DC, Heilman RL, Chakkera HA, Andrews PE, Moss AA. Diffuse parenchymal urine leak after kidney transplantation following degloving injury during donor nephrectomy. Am J Transplant. 2007 Aug; 7(8):2039-41. Epub 2007 Jun 18.
    View PubMed
  51. *Pasha SF, Harrison ME, Das A, Nguyen CC, Vargas HE, Balan V, Byrne TJ, Douglas DD, Mulligan DC. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc. 2007 Jul; 66(1):44-51.
    View PubMed
  52. Sachdev MS, Blair JE, Mulligan DC, Kusne S. Coccidioidomycosis masked by symptoms of end-stage liver disease in transplant candidates. Transpl Infect Dis. 2007 Jun; 9(2):153-5.
    View PubMed
  53. Blair JE, Mulligan DC. Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis. 2007 Mar; 9(1):78-82.
    View PubMed
  54. Cheruvattath R, Balan V, Stewart R, Heilman RL, Mulligan DC, Kusne S. Kluyvera co-infection in two solid organ transplant recipients: an emerging pathogen or a colonizer bystander? Transpl Infect Dis. 2007 Mar; 9(1):83-6.
    View PubMed
  55. *Pasha SF, Blair JE, Garvey PB, Gray RJ, Mulligan DC, Collins JM, Heigh RI. Hemosuccus Pancreaticus in the Era of Capsule Endoscopy and Double Balloon Enteroscopy Complicated by Multifocal Mycobacterium chelonae/abscessus Infection. Case Rep Gastroenterol. 2007; 1(1):38-47 Epub 2007 Aug 7.
    View PubMed
  56. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S105-7.
    View PubMed
  57. Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S114-6.
    View PubMed
  58. Sharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC, Wiesner RH, Balan V. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transplant. 2006 Aug; 6(8):1957-62. Epub 2006 Jun 09.
    View PubMed
  59. Heilman RL, Reddy KS, Mazur MJ, Moss AA, Post DJ, Petrides S, Mulligan DC. Acute rejection risk in kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab. Transplant Proc. 2006 Jun; 38(5):1307-13.
    View PubMed
  60. Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci. 2006 Jun; 51(6):1070-8.
    View PubMed
  61. Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl. 2006 Apr; 12(4):560-5.
    View PubMed
  62. Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant. 2005 Sep; 5(9):2244-7.
    View PubMed
  63. Orrego M, Guo LS, Reeder C, De Petris G, Balan V, Douglas DD, Byrne T, Harrison E, Mulligan D, Rodriguez-Luna H, Moss A, Reddy K, Rakela J, Vargas HE. Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transpl. 2005 Jul; 11(7):796-9.
    View PubMed
  64. Frasco PE, Poterack KA, Hentz JG, Mulligan DC. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg. 2005 Jul; 101(1):30-7, table of contents.
    View PubMed
  65. Heilman RL, Mazur MJ, Reddy KS, Moss A, Post D, Mulligan D. Steroid avoidance immunosuppression in low-risk kidney transplant recipients. Transplant Proc. 2005 May; 37(4):1785-8.
    View PubMed
  66. Faybush E, Mulligan DC, Birch BD, Sirven JI, Balan V. Liver transplant in a patient with a ventriculoperitoneal shunt. Liver Transpl. 2005 Apr; 11(4):467-8.
    View PubMed
  67. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S261-7.
    View PubMed
  68. Rodriguez-Luna H, Balan V, Sharma P, Byrne T, Mulligan D, Rakela J, Vargas HE. Hepatitis C virus infection with hepatocellular carcinoma: Not a controversial indication for liver transplantation. Transplantation. 2004 Aug 27; 78(4):580-3.
    View PubMed
  69. St Peter S, Rodriquez-Davalos MI, Rodriguez-Luna HM, Harrison EM, Moss AA, Mulligan DC. Significance of proximal biliary dilatation in patients with anastomotic strictures after liver transplantation. Dig Dis Sci. 2004 Aug; 49(7-8):1207-11.
    View PubMed
  70. Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis. 2004 Jun 1; 189(11):2037-46.
    View PubMed
  71. Mulligan DC, Reddy KS, Moss AA Jr. New preservation solutions for use in liver transplantation. Current Opinion in Organ Transplantation. 2004 Jun; 9(No 2):159-62.
    View PubMed
  72. Carey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. Liver Transpl. 2004 Apr; 10(4):529-33.
    View PubMed
  73. Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, Hansen K, Mulligan D, Moss A, Douglas DD, Balan V, Rakela J, Vargas HE. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series. Transplantation. 2004 Jan 27; 77(2):190-4.
    View PubMed
  74. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl. 2004 Jan; 10(1):36-41.
    View PubMed
  75. Rodriguez-Luna H, Vargas HE, Sharma P, Ortiz J, De Petris G, Balan V, Byrne T, Moss A, Mulligan D, Rakela J, Douglas DD. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci. 2004 Jan; 49(1):38-41.
    View PubMed
  76. Sharma P, Perri RE, Sirven JE, Zeldenrust SR, Brandhagen DJ, Rosen CB, Douglas DD, Mulligan DC, Rakela J, Wiesner RH, Balan V. Outcome of liver transplantation for familial amyloidotic polyneuropathy. Liver Transpl. 2003 Dec; 9(12):1273-80.
    View PubMed
  77. St Peter SD, Moss AA, Huettl EA, Leslie KO, Mulligan DC. Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma. Clin Transplant. 2003 Dec; 17(6):549-53.
    View PubMed
  78. Blair JE, Douglas DD, Mulligan DC. Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis. 2003 Mar; 5(1):3-8.
    View PubMed
  79. St Peter SD, Moss AA, Mulligan DC. Effects of tacrolimus on ischemia-reperfusion injury. Liver Transpl. 2003 Feb; 9(2):105-16.
    View PubMed
  80. St Peter SD, Post DJ, Rodriguez-Davalos MI, Douglas DD, Moss AA, Mulligan DC. Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation. Liver Transpl. 2003 Feb; 9(2):144-9.
    View PubMed
  81. Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Recent advances in liver transplantation. Mayo Clin Proc. 2003 Feb; 78(2):197-210.
    View PubMed
  82. St Peter SD, Nguyen CC, Mulligan DC, Moss AA. Subcutaneous metastasis at a surgical drain site after the resection of pancreatic cancer. International Journal of Gastrointestinal Cancer. 2003; 33(2-3):111-5.
    View PubMed
  83. Lefler SR, Lille ST, Huemer GM, Tucker R, Murray T, Schoeller T, Mulligan DC. Activation time course of activator protein-1 and effect of proline dithiocarbamate during ischemia-reperfusion in rat skeletal muscle. Ann Plast Surg. 2002 Dec; 49(6):654-9.
    View PubMed
  84. Lefler SR, St Peter SD, Rodriguez-Davalos MI, Perumean JC, Spence NA, Moss AA, Mulligan DC. Amelioration of hepatic ischemia/reperfusion injury using indolepropionic acid. Transplant Proc. 2002 Dec; 34(8):3065-6.
    View PubMed
  85. Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl. 2002 Nov; 8(11):1014-9.
    View PubMed
  86. Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O'Brien PC, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL. A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation. 2002 Jun 27; 73(12):1904-9.
    View PubMed
  87. Molmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung G, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Elliott EE, Bursac N, Mulligan D, Gonwa TA, Klintmalm GB. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg. 2002 Feb;235(2):292-6.
    View PubMed
  88. Abbas MA, Collins JM, Mulligan DC. Renal cell carcinoma metastatic to pancreas. Am J Surg. 2001 Aug; 182(2):183-4.
    View PubMed
  89. Mulligan DC. Resection vs. Transplantation for Hepatocellular Carcinoma. Audio-Digest Gastroenterology. 2001 Jul; 15(7).
  90. Lille ST, Lefler SR, Mowlavi A, Suchy H, Boyle EM Jr, Farr AL, Su CY, Frank N, Mulligan DC. Inhibition of the initial wave of NF-kappaB activity in rat muscle reduces ischemia/reperfusion injury. Muscle & Nerve. 2001 Apr; 24(4):534-41.
    View PubMed
  91. Abbas MA, Mulligan DC, Ramzan NN, Blair JE, Smilack JD, Shapiro MS, Lidner TK, Olden KW. Colonic perforation in unsuspected amebic colitis. Dig Dis Sci. 2000 Sep; 45(9):1836-41.
    View PubMed
  92. Molmenti EP, Roodhouse TW, Jaiswal K, Jennings LW, Sanchez EQ, Marubashi S, Jung G, Brooks BK, Conkey A, Mulligan DC, Levy MF, Goldstein RM, Klintmalm GB. Portal vein thrombendvenectomy in cases of organized portal vein thrombosis at the time of liver transplantation. Transplantation. 2000 Apr; 69(8):Suppl S, 242.
  93. Post AB, Mulligan DC, Bush W. Cost analysis of four strategies for prevention of CMV infection in liver transplant recipients. Transplant Proc. 1998 Aug; 30(5):2102-3.
    View PubMed
  94. Chitale AA, Sterling RK, Post AB, Silver BJ, Mulligan DC, Schulak JA. Resolution of spur cell anemia with liver transplantation: a case report and review of the literature. Transplantation. 1998 Apr 15; 65(7):993-5.
    View PubMed
  95. Harwell CM, Newman LN, Cacho CP, Mulligan DC, Schulak JA, Friedlander MA. Abdominal catastrophe: visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis. Perit Dial Int. 1997 Nov-Dec; 17(6):586-94.
    View PubMed
  96. Ghandour FZ, Knauss TC, Mulligan DC, Schulak JA, Hricik DE. Influence of steroid withdrawal on proteinuria in renal allograft recipients. Clin Transplant. 1997 Oct; 11(5 Pt 1):395-8.
    View PubMed
  97. Schulak JA, Mulligan DC, Robinson A. Intrathymic spleen cell inoculation and ALS fails to induce tolerance to rat pancreas allografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1070-1.
    View PubMed
  98. Schulak J, May E, Post A, Fasola C, Mulligan D, Sterling R. Reduction of early rejection in adult liver transplantation with ATG induction therapy. Transplant Proc. 1997 Feb-Mar; 29(1-2):555-6.
    View PubMed
  99. Mulligan D, Gentry L, Dombrausky L, Klintmalm G, Nikaein A. Monitoring of allograft recipients for the development of HLA-specific antibodies: elimination of OKT3 as a complicating factor. Clin Transplant. 1995 Dec; 9(6):438-41.
    View PubMed
  100. Mulligan DC, Klintmalm GB. Should liver transplantation be performed for hepatitis B? Clin Transplant. 1995 Jun; 9(3 Pt 2):246-8.
    View PubMed
  101. Levy MF, Jennings L, Abouljoud MS, Mulligan DC, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Quality of life improvements at one, two, and five years after liver transplantation. Transplantation. 1995 Feb 27; 59(4):515-8.
    View PubMed
  102. Mulligan DC, Goldstein RM, Crippin JS, Abouljoud MS, Levy MF, Husberg BS, Gonwa TA, Foster BR, Tillery GW, Klintmalm GB. Use of anti-hepatitis C virus seropositive organs in liver transplantation. Transplant Proc. 1995 Feb; 27(1):1204-5.
    View PubMed
  103. Abouljoud MS, Levy MF, Rees CR, Diamond NG, Lee SP, Mulligan DC, Goldstein RM, Husberg B, Gonwa TA, Klintmalm GB. A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation. Transplantation. 1995 Jan 27; 59(2):226-9.
    View PubMed
  104. Holmberg S, Levy M, Goldstein R, Husberg B, Mulligan DC, Gonwa T, Brooks B, Jennings L, Klintmalm G. Lymphoma after liver transplantation - a single center clinical and epidemiological experience. Swedish Journal of Medicine. 1994.
  105. Mulligan DC, McHenry CR, Kinney W, Esselstyn CB. Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy. Surgery. 1993 Dec; 114(6):1114-9.
    View PubMed
  106. Levy MF, Goldstein RM, Husberg BS, Gonwa TA, Backman L, Abouljoud M, Mulligan D, Klintmalm GB. Baylor update: outcome analysis in liver transplantation. Clin Transpl. 1993; 161-73.